K

Kangji Medical Holdings Ltd
HKEX:9997

Watchlist Manager
Kangji Medical Holdings Ltd
HKEX:9997
Watchlist
Price: 6.46 HKD 1.41% Market Closed
Market Cap: 7.6B HKD
Have any thoughts about
Kangji Medical Holdings Ltd?
Write Note

Kangji Medical Holdings Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kangji Medical Holdings Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
K
Kangji Medical Holdings Ltd
HKEX:9997
Accounts Receivables
ÂĄ225.5m
CAGR 3-Years
37%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Accounts Receivables
ÂĄ6.3B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Accounts Receivables
ÂĄ971.3m
CAGR 3-Years
9%
CAGR 5-Years
19%
CAGR 10-Years
8%
Autobio Diagnostics Co Ltd
SSE:603658
Accounts Receivables
ÂĄ1.2B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Accounts Receivables
ÂĄ768.6m
CAGR 3-Years
-3%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Accounts Receivables
ÂĄ620.5m
CAGR 3-Years
42%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Kangji Medical Holdings Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.

Intrinsic Value
10.28 HKD
Undervaluation 37%
Intrinsic Value
Price
K

See Also

What is Kangji Medical Holdings Ltd's Accounts Receivables?
Accounts Receivables
225.5m CNY

Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Accounts Receivables amounts to 225.5m CNY.

What is Kangji Medical Holdings Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
36%

Over the last year, the Accounts Receivables growth was 38%. The average annual Accounts Receivables growth rates for Kangji Medical Holdings Ltd have been 37% over the past three years , 36% over the past five years .

Back to Top